| scholarly article | Q13442814 |
| P2093 | author name string | Ping Zhang | |
| Jianzhong Liu | |||
| Xu Feng | |||
| Suzanne M Michalek | |||
| Nasser Said-Al-Naief | |||
| Shunqing Wang | |||
| P2860 | cites work | Stimulation by toll-like receptors inhibits osteoclast differentiation | Q24301850 |
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients | Q24550658 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src | Q28142620 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| The TNF and TNF receptor superfamilies: integrating mammalian biology | Q28203717 | ||
| Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 | ||
| A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function | Q28364534 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Osteoclast differentiation and activation | Q29547556 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism | Q30157499 | ||
| Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors | Q32024958 | ||
| Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL) | Q73907464 | ||
| Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1 | Q74424521 | ||
| TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-alpha autocrine signalling | Q79880502 | ||
| Functional identification of three receptor activator of NF-kappa B cytoplasmic motifs mediating osteoclast differentiation and function | Q80865746 | ||
| Receptor activator of NF-kappaB (RANK) cytoplasmic motif, 369PFQEP373, plays a predominant role in osteoclast survival in part by activating Akt/PKB and its downstream effector AFX/FOXO4 | Q81424180 | ||
| A novel receptor activator of NF-kappaB (RANK) cytoplasmic motif plays an essential role in osteoclastogenesis by committing macrophages to the osteoclast lineage | Q82062490 | ||
| Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts | Q33939357 | ||
| Dental biofilms: difficult therapeutic targets | Q34128638 | ||
| All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction | Q34543653 | ||
| Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection | Q35008871 | ||
| Humoral immune responses in gingival crevice fluid: local and systemic implications | Q35092097 | ||
| Hard labour: bacterial infection of the skeleton. | Q35601796 | ||
| Modulation of osteoclast differentiation | Q35957509 | ||
| The bacterial etiology of destructive periodontal disease: current concepts | Q36056602 | ||
| Regulatory roles and molecular signaling of TNF family members in osteoclasts | Q36074904 | ||
| Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease | Q36703949 | ||
| Novel host response therapeutic approaches to treat periodontal diseases. | Q36703987 | ||
| Signaling to NF-kappaB by Toll-like receptors | Q37009320 | ||
| RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
| Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. | Q37372701 | ||
| TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand | Q37413745 | ||
| Microbial complexes in subgingival plaque | Q38553206 | ||
| Effects of prostaglandin E2 and lipopolysaccharide on osteoclastogenesis in RAW 264.7 cells | Q39567498 | ||
| Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. | Q39655080 | ||
| Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells | Q39792472 | ||
| Bacterially induced bone destruction: mechanisms and misconceptions. | Q39825282 | ||
| Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells | Q40114184 | ||
| A synthetic analog of alpha-galactosylceramide induces macrophage activation via the TLR4-signaling pathways | Q40143681 | ||
| Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. | Q40745157 | ||
| Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling | Q40756889 | ||
| Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. | Q40870297 | ||
| Osteoclasts, macrophages, and the molecular mechanisms of bone resorption | Q41431482 | ||
| Periodontal diseases: microbial factors | Q41444992 | ||
| The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | Q41649459 | ||
| Mechanisms of alveolar bone destruction in periodontitis. | Q41754991 | ||
| Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. | Q43775920 | ||
| Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. | Q43864464 | ||
| Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages | Q44343190 | ||
| Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice | Q44779377 | ||
| Appearance of osteoclasts by injections of lipopolysaccharides in rat periodontal tissue | Q44976066 | ||
| Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats. | Q51670417 | ||
| Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. | Q53768934 | ||
| RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β | Q57675150 | ||
| Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling | Q58085461 | ||
| Dual Modulation of Osteoclast Differentiation by Lipopolysaccharide | Q58456589 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| Quantitative analyses of osteoclast changes in resorbing bone organ cultures | Q67674065 | ||
| The effect of lipopolysaccharide from the oral bacterium Bacteroides gingivalis on osteoclastic resorption of sperm-whale dentine slices in vitro | Q68841823 | ||
| Bone resorption stimulated by lipopolysaccharides from Bacteroides, Fusobacterium and Veillonella, and by the lipid A and the polysaccharide part of Fusobacterium lipopolysaccharide | Q70156593 | ||
| Comparison of the mechanisms of bone resorption induced by 1 alpha,25-dihydroxyvitamin D3 and lipopolysaccharides | Q70298423 | ||
| Facial skeletal growth in growing "toothless" osteopetrotic (op/op) mice: radiographic findings | Q73579680 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipopolysaccharide | Q421804 |
| P304 | page(s) | 12512-12523 | |
| P577 | publication date | 2009-03-03 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis | |
| P478 | volume | 284 |
| Q54286064 | Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages. |
| Q36315765 | Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts |
| Q84380039 | Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes |
| Q98465737 | Chronic Exposure of Gingival Fibroblasts to TLR2 or TLR4 Agonist Inhibits Osteoclastogenesis but Does Not Affect Osteogenesis |
| Q42270419 | Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein |
| Q47104810 | Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis |
| Q50137945 | Dietary Fats and Osteoarthritis: Insights, Evidences, and New Horizons |
| Q40332591 | Effect of Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) on the expression of EphA2 in osteoblasts and osteoclasts |
| Q39344809 | Effects of Porphyromonas gingivalis surface-associated material on osteoclast formation |
| Q39490131 | Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation |
| Q26863571 | Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8 |
| Q92405045 | Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation |
| Q37238209 | Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function |
| Q36444288 | IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1). |
| Q34313876 | Infection of RANKL-primed RAW-D macrophages with Porphyromonas gingivalis promotes osteoclastogenesis in a TNF-α-independent manner |
| Q37438518 | Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors |
| Q39018581 | Involvement of redox balance in in vitro osteoclast formation of RAW 264.7 macrophage cells in response to LPS. |
| Q36188882 | Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response |
| Q64060861 | MicroRNA-29b Enhances Osteoclast Survival by Targeting BCL-2-Modifying Factor after Lipopolysaccharide Stimulation |
| Q27315989 | Modulation of osteoclastogenesis with macrophage M1- and M2-inducing stimuli |
| Q35664993 | Molecular mechanisms of the biphasic effects of interferon-γ on osteoclastogenesis |
| Q41583248 | NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis |
| Q36257329 | Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activators |
| Q39475508 | Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue |
| Q89818128 | Osteoclastogenesis in Periodontal Diseases: Possible Mediators and Mechanisms |
| Q35890262 | Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion |
| Q38741964 | PKR regulates LPS-induced osteoclast formation and bone destruction in vitro and in vivo |
| Q42124151 | Plasmin is essential in preventing periodontitis in mice |
| Q37609527 | Protective effects of recombinant human cytoglobin against chronic alcohol-induced liver disease in vivo and in vitro |
| Q36751534 | Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss. |
| Q33916514 | Retracted: Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis |
| Q35666187 | Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling |
| Q55171215 | Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function. |
| Q34774474 | Secretion of a truncated osteopetrosis-associated transmembrane protein 1 (OSTM1) mutant inhibits osteoclastogenesis through down-regulation of the B lymphocyte-induced maturation protein 1 (BLIMP1)-nuclear factor of activated T cells c1 (NFATc1) ax |
| Q36356941 | Serum amyloid A inhibits RANKL-induced osteoclast formation |
| Q35085107 | TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB. |
| Q38289811 | TLR4 signalling in osteoarthritis--finding targets for candidate DMOADs. |
| Q37287589 | The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis |
| Q47953854 | The expression of ERK and JNK in patients with an endemic osteochondropathy, Kashin-Beck disease |
| Q45422823 | The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation |
| Q38763612 | The osteoimmunology of alveolar bone loss |
| Q35987370 | The role of SH3BP2 in the pathophysiology of cherubism |
| Q28385635 | Toll-Like Receptor 4 Signaling Pathway Mediates Inhalant Organic Dust-Induced Bone Loss |
| Q54977323 | Toll-like receptor 2 activation primes and upregulates osteoclastogenesis via lox-1. |
| Q35386678 | Toll-like receptor 4 mediates the regenerative effects of bone grafts for calvarial bone repair |
| Q39550193 | Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation |
| Q37360437 | γ-Glutamyltranspeptidase is an endogenous activator of Toll-like receptor 4-mediated osteoclastogenesis |
Search more.